When Help Hurts Instead

Drugs and medical products are meant to help cure us when we're sick and improve the quality of life. Many times the results are impressive. But sometimes, a drug that was meant to help ends up hurting us instead. This can happen when a drug is not properly tested, when it is prescribed incorrectly, or when it causes an unexpected side effect. Some drugs have serious side effects and have the potential to cause long-term damage, including death.

Levy Baldante has the reputation of vigorously representing the interests of victims who have been tragically affected by pharmaceuticals and medical products. As with our specialty in medical malpractice, we have developed the resources and the skill needed to obtain the most favorable outcomes on behalf of our clients.

Vioxx Litigation

Vioxx®, a popular prescription pain relief medication has been withdrawn from the United States market on September 30, 2004 by its manufacturer, New Jersey based Merck & Company. Read More...

Baycol Litigation

Baycol® (generically-cerivastatin), a popular prescription cholesterol medication, has been withdrawn from the United States market on August 8, 2001 by its manufacturer, Bayer Corporation. Read More...

Fen-Phen Litigation

On September 15, 1997, American Home Products Corporation ("AHP") withdrew the diet drugs Pondimin® and Redux™ from the market. These drugs had been commonly prescribed by physicians alone and/or in combination with other prescription drugs (specifically, Phentermine) for weight loss. The combination of drugs was popularly known as "Fen-Phen." Read More...

Phenylpropanolamine ("PPA")

Phenylpropanolamine (“PPA”) has been associated with causing hemorrhagic strokes. PPA is or was a common ingredient in over the counter cold remedies and appetite suppressants. On November 6, 2000 the Food and Drug Administration (FDA) issued a public health advisory about the risk of hemorrhagic strokes when using OTC medications containing PPA. Read More...

Ephedra Litigation

Ephedrine is the active alkaloid ingredient obtained from the stems of a shrub “Ephedra” a/k/a “Ma Huang”, and is essentially the botanical form of PPA (Phenylpropanolamine). Read More...

Rezulin Litigation

Our firm’s medical and Drug Product Injury practice group represents individuals who suffered injury due to their prescription use of Rezulin™ (troglitazone). Read More...

Propulsid Litigation

Propulsid (Cisapride), a popular prescription heart burn medication, has been associated with serious cardiac arrhythmias, including ventricular tachycardia, atrial and ventricular brachycardia, ventricular fibrillation, torsades de pointes, and “QT” prolongation. Read More...

St. Jude Heart Valve Devices Litigation

In January 2000, the manufacturer withdrew this line of prosthetic mechanical heart valves with a silver based coating known as “Silzone” from the marketplace because of an increased incidence of failure in comparison to similar valves without the Silzone coating. Read More...